BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, July 7, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Self-amplifying mRNA technology underscored for next big pandemic
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
INSERM and Bioprojet describe a new histamine H3 receptor antagonist
Sep. 6, 1996
Tiagabine clinical data reported at congress this week
Sep. 6, 1996
Fosphenytoin launch imminent
Sep. 6, 1996
Mechanism-based enzyme inhibitor may serve as a lead for new anticonvulsants
Sep. 6, 1996
NS-2389: a potential new antidepressant
Sep. 6, 1996
Reversible MAO inhibitors from Hoechst Marion Roussel
Sep. 6, 1996
Lilly's olanzapine deemed approvable
Sep. 6, 1996
Antipsychotic dopaminergic compounds from E. Merck
Sep. 6, 1996
Lilly discloses new serotonergic agents
Sep. 6, 1996
NS-2710 in development for anxiety
Sep. 6, 1996
Previous
1
2
…
2710
2711
2712
2713
2714
2715
2716
2717
2718
…
2751
2752
Next
RSS